Saturday, 5 August 2017
Price erosion in pharma worse than anticipated: R Sreesankar, Prabhudas Lilladher
Talking to ET Now, R Sreesankar, Head Institutional Equities, Prabhudas Lilladher , says price erosion in the US generics is going to be a bigger worry. ET Now: What is your take on pharmaceuticals? How should investors approach them?
You can read more here: Price erosion in pharma worse than anticipated: R Sreesankar, Prabhudas Lilladher
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
No comments:
Post a Comment